BIO International Convention 2026 Market Contacts & Industry Guide
A practical resource for understanding the companies, therapy areas, decision roles and partnership objectives associated with BIO 2026—plus customized business contact research for biotechnology, pharmaceutical and life-sciences campaigns.
A1 Data is an independent B2B data provider. It is not affiliated with, sponsored by, endorsed by or officially connected with BIO or the event organizer. The service described here is customized business contact research, not the sale of BIO’s official registration database.
A market guide first, a contact request page second
Google’s people-first guidance rewards pages that genuinely help visitors understand a subject. This page therefore explains BIO’s market structure, partnering logic, company categories and decision roles before presenting A1 Data’s customized audience-research service.
What BIO International Convention 2026 represented
BIO 2026 was held June 22–25 at the San Diego Convention Center. The convention brought together the biotechnology ecosystem through scientific programming, business development, company presentations, policy discussions, investor engagement, one-to-one partnering and exhibition activity.
Program scale and focus areas
Official BIO information described a program of more than 130 sessions across 18 focus areas. The subject mix included business development, AI and digital health, patient advocacy, public policy, next-generation biotherapeutics, infectious diseases and vaccines, among other biotechnology priorities.
The BIO partnering ecosystem
BIO is strongly associated with business-development and partnering activity. Relevant participants may be evaluating therapeutic assets, platform technologies, regional licensing rights, research collaborations, manufacturing capacity, clinical capabilities or investment opportunities.
Licensing and alliances
Therapeutic assets, platform access, co-development, commercialization and regional-rights discussions.
Research and clinical collaboration
Translational research, trial execution, biomarker work, diagnostics and specialist development services.
Manufacturing and supply
Process development, scale-up, analytical work, quality, fill-finish, cold chain and supply resilience.
Company and organization categories
A campaign can be structured around company type rather than a broad “event attendee” label. Examples include the following biotechnology and life-sciences segments.
Therapy areas and enabling technologies
Therapy-area and technology filters make a contact audience more useful. A company selling oncology biomarker services should not use the same targeting criteria as a cell-therapy CDMO or a clinical-trial software provider.
Decision roles mapped to campaign objectives
Select professional functions based on the business action you want to influence. The table below illustrates why role selection should change with the campaign.
| Campaign objective | Relevant professional functions |
|---|---|
| Licensing or collaboration | Chief Business Officer, Business Development VP, Licensing Director, Alliance Management Director, External Innovation Lead |
| Clinical services | Clinical Development Director, Clinical Operations VP, Medical Director, Biometrics Lead, Vendor Management Director |
| Research tools or platforms | Chief Scientific Officer, Research Director, Translational Medicine Lead, Laboratory Director, Principal Scientist |
| Manufacturing services | CMC Director, Biomanufacturing VP, Technical Operations Director, Supply Chain Director, Strategic Sourcing Lead |
| Investment or corporate development | CEO, CFO, Corporate Development Director, Strategy VP, Venture Partner, Investment Principal |
Post-event and future-planning use cases
BIO 2026 concluded on June 25, 2026. The most useful campaigns now are transparent post-event follow-up, account research, supplier mapping and future event planning—not outdated “book a meeting before BIO” messaging.
Post-event follow-up
Continue a relevant conversation with organizations whose market, therapy area or function aligns with your offer.
Account and partner research
Build a map of biotechnology companies, investors, service providers and research organizations.
BIO 2027 preparation
Use the market structure to define priority accounts, roles and messages ahead of the next convention.
Business fields that may be available
A1 Data should state field availability accurately. Not every record will contain every field, and a customized count should be reviewed before the project is finalized.
Professional
- Name
- Job title
- Department
- Seniority
Contact
- Business email where verified
- Business phone where available
- Profile URL where available
Company
- Organization
- Website
- Industry
- Employee or revenue range where available
Location
- Business address
- City
- State or region
- Country
How a customized audience is built
1. Define the business outcome
Licensing, supplier discovery, sales, recruitment, investment research or scientific collaboration.
2. Select the market
Therapy area, enabling technology, company category, geography and organization size.
3. Select decision roles
Choose the professional functions and seniority levels connected to the intended action.
4. Review scope
Confirm available fields, estimated volume, pricing and delivery format before completion.
Responsible business outreach
Customers are responsible for applying the laws, regulations, contractual requirements and platform policies relevant to their activities. Good outreach is specific, transparent and easy to decline.
- Identify your organization and the business purpose of the communication.
- Use a relevant reason for contacting the recipient.
- Do not imply endorsement or an official relationship with BIO.
- Provide an appropriate opt-out method and honor suppression requests.
- Avoid misleading subject lines, unsupported claims and excessive message frequency.
About A1 Data’s role
A1 Data provides customized B2B contact research. The service should be described as a market and business-contact research service—not as ownership of an official BIO registration database. This distinction improves clarity for users and reduces the risk of misleading claims.
BIO 2026 market-contact FAQs
Clear answers about the event, the audience-research service and responsible use.
Is A1 Data selling BIO’s official registration list?
No. A1 Data is an independent B2B data provider and does not claim to own or sell BIO’s official registration database. It provides customized business contact research using the market, company and role criteria requested by the customer.
Can I request biotechnology and pharmaceutical companies?
Yes. Requests may be organized around biotechnology companies, pharmaceutical organizations, CROs, CDMOs, investors, research institutes, diagnostics firms, laboratories and other relevant business categories.
Can the audience be filtered by therapy area?
Yes, subject to available company and professional information. Examples include oncology, cell and gene therapy, rare disease, neuroscience, immunology, infectious disease, vaccines and diagnostics.
Can I select specific professional roles?
Yes. Possible functions include business development, licensing, alliance management, external innovation, clinical development, research, manufacturing, procurement, corporate development and technology transfer.
What business fields may be included?
Available fields may include name, job title, department, company, business email, business phone, website, business address, geography, company size and professional profile URL. Availability varies by record.
How is the completed file delivered?
The approved audience can be organized in Excel or CSV format based on the agreed fields and segmentation criteria.
Can the information support post-event follow-up?
Yes, when the outreach is relevant, transparent and compliant with the requirements that apply to the sender and intended market.
How do I receive an estimated count and price?
Submit the form with your desired market, roles, geography and fields. A1 Data will review the requirement and respond with estimated availability, pricing and delivery information.
Define the biotechnology market you need to reach
Share your company categories, therapy areas, roles, countries and preferred business fields for a focused audience review.